Cost-effectiveness of screening for proteinuria.
Publication
, Journal Article
Gansevoort, RT; de Jong, PE; Postma, MJ
Published in: JAMA
March 24, 2004
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 24, 2004
Volume
291
Issue
12
Start / End Page
1442 / 1443
Location
United States
Related Subject Headings
- Proteinuria
- Mass Screening
- Kidney Diseases
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- Albuminuria
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gansevoort, R. T., de Jong, P. E., & Postma, M. J. (2004). Cost-effectiveness of screening for proteinuria. JAMA, 291(12), 1442–1443. https://doi.org/10.1001/jama.291.12.1442
Gansevoort, Ron T., Paul E. de Jong, and Maarten J. Postma. “Cost-effectiveness of screening for proteinuria.” JAMA 291, no. 12 (March 24, 2004): 1442–43. https://doi.org/10.1001/jama.291.12.1442.
Gansevoort RT, de Jong PE, Postma MJ. Cost-effectiveness of screening for proteinuria. JAMA. 2004 Mar 24;291(12):1442–3.
Gansevoort, Ron T., et al. “Cost-effectiveness of screening for proteinuria.” JAMA, vol. 291, no. 12, Mar. 2004, pp. 1442–43. Pubmed, doi:10.1001/jama.291.12.1442.
Gansevoort RT, de Jong PE, Postma MJ. Cost-effectiveness of screening for proteinuria. JAMA. 2004 Mar 24;291(12):1442–1443.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 24, 2004
Volume
291
Issue
12
Start / End Page
1442 / 1443
Location
United States
Related Subject Headings
- Proteinuria
- Mass Screening
- Kidney Diseases
- Humans
- General & Internal Medicine
- Cost-Benefit Analysis
- Albuminuria
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences